| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8285935 | Parkinsonism & Related Disorders | 2016 | 6 Pages |
Abstract
TD versus PIGD subtype classification has substantial variability over first year in PD de novo cohort specifically for PIGD subtype. Dopaminergic therapy does not impact the change of the PD subtype. This instability has to be taken into consideration specifically when establishing correlations with the biomarkers and for long term prognostication.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Tanya Simuni, Chelsea Caspell-Garcia, Christopher Coffey, Shirley Lasch, Caroline Tanner, Ken Marek, PPMI Investigators PPMI Investigators,